InflaRx (IFRX)
(Delayed Data from NSDQ)
$0.80 USD
-0.01 (-1.83%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $0.80 0.00 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, InflaRx N.V. has a market cap of $54.72M, which represents its share price of $0.82 multiplied by its outstanding shares number of 67.13M. As a small-cap company, IFRX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
IFRX 0.80 -0.01(-1.83%)
Will IFRX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IFRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IFRX
InflaRx N.V. (IFRX) Reports Q2 Loss, Misses Revenue Estimates
Axsome Therapeutics (AXSM) Reports Q2 Loss, Beats Revenue Estimates
IFRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Aligos Therapeutics, Inc. (ALGS) Reports Q1 Loss, Misses Revenue Estimates
InflaRx (IFRX) Loses -15.29% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
InflaRx Stock Rises 8% on Conditional EC Nod for COVID-19 Drug
Other News for IFRX
InflaRx reports Q2 EPS (21c) vs. (24c) last year
InflaRx Reports Second Quarter 2025 Financial Results and Provides Business Update | IFRX Stock News
InflaRx reports Q2 results
InflaRx to Report Second Quarter 2025 Results on August 7, 2025 | IFRX Stock News
InflaRx (IFRX) Faces Nasdaq Listing Challenge Due to Low Share Price | IFRX Stock News